INC Research Holdings, Inc. is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:INCR
- CUSIP: N/A
- Web: www.incresearch.com
Capitalization:- Market Cap: $3.08423 billion
- Outstanding Shares: 54,157,000
Average Prices:- 50 Day Moving Avg: $58.28
- 200 Day Moving Avg: $51.52
- 52 Week Range: $40.65 - $61.10
P/E:- Trailing P/E Ratio: 26.97
- Foreward P/E Ratio: 20.04
- P/E Growth: 1.51
Sales & Book Value:- Annual Revenue: $1.03 billion
- Price / Sales: 2.98
- Book Value: $6.20 per share
- Price / Book: 9.15
Profitability:- EBIDTA: $230.43 million
- Net Margins: 7.37%
- Return on Equity: 43.17%
- Return on Assets: 10.10%
Debt:- Debt-to-Equity Ratio: 1.40%
- Current Ratio: 1.18%
- Quick Ratio: 1.18%
Misc:- Average Volume: 973,216 shs.
- Beta: 1.47
- Short Ratio: 3.89
Frequently Asked Questions for INC Research Holdings (NASDAQ:INCR)
What is INC Research Holdings' stock symbol?
INC Research Holdings trades on the NASDAQ under the ticker symbol "INCR."
How were INC Research Holdings' earnings last quarter?
INC Research Holdings, Inc. (NASDAQ:INCR) issued its earnings results on Wednesday, May, 10th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.55 by $0.05. The business earned $252.10 million during the quarter, compared to analysts' expectations of $250.76 million. INC Research Holdings had a return on equity of 43.17% and a net margin of 7.37%. The company's revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.58 EPS. View INC Research Holdings' Earnings History.
What guidance has INC Research Holdings issued on next quarter's earnings?
INC Research Holdings issued an update on its FY17 earnings guidance on Wednesday, May, 10th. The company provided earnings per share guidance of $2.66-2.74 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.66. The company issued revenue guidance of $1.04-1.07 billion, compared to the consensus revenue estimate of $1.06 billion.
Where is INC Research Holdings' stock going? Where will INC Research Holdings' stock price be in 2017?
8 brokers have issued 1 year target prices for INC Research Holdings' stock. Their predictions range from $51.00 to $68.00. On average, they anticipate INC Research Holdings' share price to reach $62.50 in the next twelve months. View Analyst Ratings for INC Research Holdings.
Who are some of INC Research Holdings' key competitors?
Some companies that are related to INC Research Holdings include United Therapeutics Corporation (UTHR), Icon Plc (ICLR), Charles River Laboratories International (CRL), PRA Health Sciences (PRAH), Exact Sciences Corporation (EXAS), PAREXEL International Corporation (PRXL), Bio-Techne Corp (TECH), Galapagos NV (GLPG), Portola Pharmaceuticals (PTLA), ACADIA Pharmaceuticals (ACAD), Nektar Therapeutics (NKTR), Puma Biotechnology (PBYI), WuXi PharmaTech (Cayman) (WX), Sage Therapeutics (SAGE), Intrexon Corporation (XON), Ligand Pharmaceuticals Incorporated (LGND), Ironwood Pharmaceuticals (IRWD) and FibroGen (FGEN).
Who are INC Research Holdings' key executives?
INC Research Holdings' management team includes the folowing people:
- Alistair Macdonald, Chief Executive Officer, Director
- Gregory S. Rush, Chief Financial Officer, Executive Vice President
- Michael Gibertini Ph.D., Chief Operating Officer
- Christopher L. Gaenzle, Chief Administrative Officer, General Counsel, Secretary
- David York Norton, Non-Executive Independent Chairman of the Board
- Robert W. Breckon, Independent Director
- David F. Burgstahler, Independent Director
- Linda S. Harty, Independent Director
- Richard N. Kender, Independent Director
Who owns INC Research Holdings stock?
INC Research Holdings' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Acadian Asset Management LLC (2.45%), GW&K Investment Management LLC (1.55%), Russell Investments Group Ltd. (1.20%), Copper Rock Capital Partners LLC (0.88%), AMI Asset Management Corp (0.49%) and Malaga Cove Capital LLC (0.26%). Company insiders that own INC Research Holdings stock include Alistair Macdonald, Avista Capital Partners Ii Gp,, Christopher L Gaenzle, D Jamie Macdonald, David F Burgstahler, Gregory S Rush, James T Ogle, Michael Gibertini, Robert W Breckon and Teachers Pension Plan Ontario. View Institutional Ownership Trends for INC Research Holdings.
Who sold INC Research Holdings stock? Who is selling INC Research Holdings stock?
INC Research Holdings' stock was sold by a variety of institutional investors in the last quarter, including Boston Advisors LLC, GW&K Investment Management LLC, Eqis Capital Management Inc., Acadian Asset Management LLC, AMI Asset Management Corp, Atria Investments LLC, Malaga Cove Capital LLC and Buffington Mohr McNeal. Company insiders that have sold INC Research Holdings stock in the last year include Alistair Macdonald, Avista Capital Partners Ii Gp,, Christopher L Gaenzle, D Jamie Macdonald, Gregory S Rush, Robert W Breckon and Teachers Pension Plan Ontario. View Insider Buying and Selling for INC Research Holdings.
Who bought INC Research Holdings stock? Who is buying INC Research Holdings stock?
INC Research Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Russell Investments Group Ltd., State Treasurer State of Michigan, Oregon Public Employees Retirement Fund, Louisiana State Employees Retirement System, Aperio Group LLC, Capstone Asset Management Co. and Legato Capital Management LLC. View Insider Buying and Selling for INC Research Holdings.
How do I buy INC Research Holdings stock?
Shares of INC Research Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is INC Research Holdings' stock price today?
One share of INC Research Holdings stock can currently be purchased for approximately $56.70.
MarketBeat Community Rating for INC Research Holdings (NASDAQ INCR)MarketBeat's community ratings are surveys of what our community members think about INC Research Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for INC Research Holdings (NASDAQ:INCR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Hold Ratings, 4 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.50) |
| Consensus Price Target: | $62.50 (10.23% upside) |
Analysts' Ratings History for INC Research Holdings (NASDAQ:INCR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 6/29/2017 | Jefferies Group LLC | Downgrade | Buy -> Hold | $62.00 -> $64.00 | High |  |
| 6/20/2017 | William Blair | Downgrade | Outperform -> Market Perform | | High | |
| 6/5/2017 | KeyCorp | Upgrade | Sector Weight -> Overweight | $68.00 | Low | |
| 5/31/2017 | SunTrust Banks, Inc. | Upgrade | Hold -> Buy | $48.00 -> $67.00 | Medium | |
| 5/11/2017 | Robert W. Baird | Upgrade | Neutral -> Outperform | $46.00 -> $66.00 | Medium | |
| 5/3/2017 | Wells Fargo & Company | Downgrade | Outperform -> Market Perform | | High | |
| 3/1/2017 | Goldman Sachs Group, Inc. (The) | Downgrade | Conviction-Buy -> Buy | $51.00 | N/A | |
| 12/19/2016 | First Analysis | Initiated Coverage | Equal -> Equal Weight | $59.00 | N/A | |
| 6/20/2016 | Credit Suisse Group | Initiated Coverage | Outperform | $51.00 | N/A | |
| 4/18/2016 | Avondale Partners | Boost Price Target | Market Perform | $39.00 -> $47.00 | N/A | |
| 3/24/2016 | J P Morgan Chase & Co | Initiated Coverage | Overweight | $47.00 | N/A | |
(Data available from 7/26/2015 forward)
Earnings History for INC Research Holdings (NASDAQ:INCR)Earnings History by Quarter for INC Research Holdings (NASDAQ INCR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/10/2017 | Q1 2017 | $0.55 | $0.60 | $250.76 million | $252.10 million | View | N/A | |
| 2/28/2017 | Q4 2016 | $0.67 | $0.67 | $269.00 million | $263.00 million | View | Listen | |
| 10/31/2016 | Q316 | $0.59 | $0.64 | $259.89 million | $259.56 million | View | Listen | |
| 7/27/2016 | Q216 | $0.58 | $0.61 | $252.39 million | $258.80 million | View | Listen | |
| 5/2/2016 | Q116 | $0.53 | $0.58 | $237.78 million | $249.00 million | View | Listen | |
| 2/25/2016 | Q415 | $0.49 | $0.54 | $239.31 million | $241.40 million | View | Listen | |
| 10/29/2015 | Q3 | $0.44 | $0.58 | $230.60 million | $234.50 million | View | Listen | |
| 7/30/2015 | Q215 | $0.34 | $0.47 | $219.08 million | $227.40 million | View | Listen | |
| 4/27/2015 | Q115 | $0.26 | $0.41 | $211.20 million | $308.90 million | View | Listen | |
| 2/24/2015 | Q414 | $0.21 | $0.24 | $207.88 million | $213.70 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for INC Research Holdings (NASDAQ:INCR)2017 EPS Consensus Estimate: $2.58
2018 EPS Consensus Estimate: $2.69
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $0.56 | $0.64 | $0.61 |
| Q2 2017 | 3 | $0.56 | $0.64 | $0.60 |
| Q3 2017 | 4 | $0.63 | $0.70 | $0.66 |
| Q4 2017 | 5 | $0.65 | $0.75 | $0.71 |
| Q1 2018 | 1 | $0.61 | $0.61 | $0.61 |
| Q2 2018 | 1 | $0.65 | $0.65 | $0.65 |
| Q3 2018 | 1 | $0.71 | $0.71 | $0.71 |
| Q4 2018 | 1 | $0.72 | $0.72 | $0.72 |
(Data provided by Zacks Investment Research)
Dividend History for INC Research Holdings (NASDAQ:INCR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for INC Research Holdings (NASDAQ:INCR)Insider Ownership Percentage: 0.24%
Institutional Ownership Percentage: 98.70%
Insider Trades by Quarter for INC Research Holdings (NASDAQ:INCR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/3/2017 | Alistair Macdonald | CEO | Sell | 10,555 | $58.38 | $616,200.90 | |
| 6/30/2017 | Christopher L Gaenzle | CAO | Sell | 6,873 | $58.32 | $400,833.36 | |
| 5/1/2017 | Alistair Macdonald | CEO | Sell | 9,467 | $45.00 | $426,015.00 | |
| 4/3/2017 | Christopher L Gaenzle | CAO | Sell | 4,733 | $45.70 | $216,298.10 | |
| 3/3/2017 | Alistair Macdonald | CEO | Sell | 8,828 | $45.00 | $397,260.00 | |
| 1/20/2017 | Alistair Macdonald | CEO | Sell | 1,375 | $50.50 | $69,437.50 | |
| 1/20/2017 | Christopher L Gaenzle | CAO | Sell | 1,186 | $50.09 | $59,406.74 | |
| 1/19/2017 | Gregory S Rush | VP | Sell | 2,907 | $50.57 | $147,006.99 | |
| 1/5/2017 | Alistair Macdonald | CEO | Sell | 14,840 | $52.19 | $774,499.60 | |
| 9/30/2016 | Gregory S Rush | VP | Sell | 35,503 | $44.70 | $1,586,984.10 | |
| 9/27/2016 | D. Jamie Macdonald | CEO | Sell | 53,970 | $44.30 | $2,390,871.00 | |
| 9/26/2016 | Robert W Breckon | Director | Sell | 12,197 | $44.16 | $538,619.52 | |
| 9/19/2016 | David F Burgstahler | Director | Buy | 1,000 | $43.19 | $43,190.00 | |
| 9/14/2016 | Christopher L Gaenzle | CAO | Sell | 4,734 | $43.14 | $204,224.76 | |
| 8/17/2016 | Alistair Macdonald | COO | Sell | 8,828 | $43.80 | $386,666.40 | |
| 8/4/2016 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 2,554,409 | $42.06 | $107,438,442.54 | |
| 8/4/2016 | Teachers Pension Plan Ontario | Director | Sell | 2,445,591 | $42.06 | $102,861,557.46 | |
| 8/2/2016 | D. Jamie Macdonald | CEO | Sell | 31,279 | $43.00 | $1,344,997.00 | |
| 8/1/2016 | Robert W Breckon | Director | Sell | 108 | $42.00 | $4,536.00 | |
| 7/28/2016 | Gregory S Rush | VP | Sell | 4,066 | $45.23 | $183,905.18 | |
| 7/20/2016 | D. Jamie Macdonald | CEO | Sell | 100,593 | $43.00 | $4,325,499.00 | |
| 7/15/2016 | Gregory S Rush | CFO | Sell | 5,917 | $41.50 | $245,555.50 | |
| 7/11/2016 | Alistair Macdonald | COO | Sell | 9,468 | $40.19 | $380,518.92 | |
| 7/11/2016 | Christopher L Gaenzle | CAO | Sell | 21,918 | $40.20 | $881,103.60 | |
| 7/1/2016 | Gregory S Rush | CFO | Sell | 1,358 | $37.97 | $51,563.26 | |
| 7/1/2016 | Robert W Breckon | Director | Sell | 421 | $37.97 | $15,985.37 | |
| 6/15/2016 | Christopher L Gaenzle | CAO | Sell | 7,702 | $40.14 | $309,158.28 | |
| 6/6/2016 | Michael Gibertini | Insider | Sell | 213,966 | $43.11 | $9,224,074.26 | |
| 6/2/2016 | Robert W Breckon | Director | Sell | 11,691 | $43.53 | $508,909.23 | |
| 5/6/2016 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,087,054 | $45.12 | $184,407,876.48 | |
| 5/6/2016 | Teachers Pension Plan Ontario | Director | Sell | 3,912,946 | $45.12 | $176,552,123.52 | |
| 4/18/2016 | James T Ogle | Director | Sell | 114,806 | $50.00 | $5,740,300.00 | |
| 4/12/2016 | D. Jamie Macdonald | CEO | Sell | 94,675 | $48.00 | $4,544,400.00 | |
| 4/1/2016 | Michael Gibertini | Insider | Sell | 9,000 | $40.78 | $367,020.00 | |
| 3/1/2016 | Michael Gibertini | Insider | Sell | 9,000 | $39.85 | $358,650.00 | |
| 2/4/2016 | Robert W. Breckon | Director | Sell | 3,882 | $40.03 | $155,396.46 | |
| 2/1/2016 | Gregory S. Rush | CFO | Sell | 17,752 | $40.27 | $714,873.04 | |
| 2/1/2016 | Michael Gibertini | insider | Sell | 9,000 | $40.57 | $365,130.00 | |
| 1/4/2016 | Michael Gibertini | insider | Sell | 9,000 | $46.83 | $421,470.00 | |
| 12/31/2015 | Alistair Macdonald | COO | Sell | 159,599 | $47.46 | $7,574,568.54 | |
| 12/31/2015 | Christopher L. Gaenzle | CAO | Sell | 9,468 | $48.18 | $456,168.24 | |
| 12/31/2015 | Gregory S. Rush | CFO | Sell | 35,503 | $48.17 | $1,710,179.51 | |
| 12/29/2015 | James T. Ogle | Director | Sell | 9,717 | $50.06 | $486,433.02 | |
| 12/8/2015 | Christopher L. Gaenzle | CAO | Sell | 25,185 | $41.78 | $1,052,229.30 | |
| 12/8/2015 | Gregory S. Rush | CFO | Sell | 81,035 | $45.13 | $3,657,109.55 | |
| 12/7/2015 | Alistair Macdonald | COO | Sell | 42,959 | $44.63 | $1,917,260.17 | |
| 12/7/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,597,937 | $45.00 | $206,907,165.00 | |
| 12/7/2015 | Teachers Pension Plan Ontario | Director | Sell | 4,402,063 | $45.00 | $198,092,835.00 | |
| 12/1/2015 | Michael Gibertini | insider | Sell | 9,000 | $46.52 | $418,680.00 | |
| 11/2/2015 | Michael Gibertini | insider | Sell | 9,000 | $41.70 | $375,300.00 | |
| 9/28/2015 | Alistair Macdonald | COO | Sell | 44,522 | $39.93 | $1,777,763.46 | |
| 9/14/2015 | Gregory S. Rush | CFO | Sell | 32,426 | $45.06 | $1,461,115.56 | |
| 8/31/2015 | Christopher L. Gaenzle | CAO | Sell | 17,421 | $41.16 | $717,048.36 | |
| 8/31/2015 | James T Ogle | Director | Sell | 55,000 | $41.12 | $2,261,600.00 | |
| 8/17/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,029,168 | $44.00 | $177,283,392.00 | |
| 8/17/2015 | Teachers Pension Plan Ontario | Director | Sell | 3,857,525 | $44.00 | $169,731,100.00 | |
| 8/12/2015 | D. Jamie Macdonald | CEO | Sell | 57,021 | $44.00 | $2,508,924.00 | |
| 8/12/2015 | Robert W Breckon | Director | Sell | 8,381 | $44.00 | $368,764.00 | |
| 5/14/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 6,599,761 | $29.68 | $195,880,906.48 | |
| 5/14/2015 | Teachers Pension Plan Ontario | Director | Sell | 6,318,607 | $29.68 | $187,536,255.76 | |
| 5/7/2015 | Gregory S Rush | CFO | Sell | 12,455 | $29.68 | $369,664.40 | |
| 5/7/2015 | Michael Gibertini | Insider | Sell | 50,000 | $29.68 | $1,484,000.00 | |
| 5/7/2015 | Robert W Breckon | Director | Sell | 8,226 | $29.68 | $244,147.68 | |
(Data available from 1/1/2013 forward)
Headline Trends for INC Research Holdings (NASDAQ:INCR)
Latest Headlines for INC Research Holdings (NASDAQ:INCR)
| Source: |
|
| Date | Headline |
|---|
 | $257.67 Million in Sales Expected for INC Research Holdings, Inc. (NASDAQ:INCR) This Quarter
www.americanbankingnews.com - July 19 at 3:46 PM |
| Zacks: Analysts Anticipate INC Research Holdings, Inc. (INCR) to Announce $0.58 Earnings Per Share
www.americanbankingnews.com - July 17 at 11:31 AM |
| Comparing INC Research Holdings (INCR) & Nektar Therapeutics (NKTR)
www.americanbankingnews.com - July 16 at 4:24 PM |
 | INC Research Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INCR-US : July 14, 2017
finance.yahoo.com - July 15 at 2:15 AM |
| Stull, Stull & Brody Announces Class Action Suit on Behalf of Shareholders of INC Research Holdings Inc. (NASDAQ: INCR)
finance.yahoo.com - July 14 at 3:51 AM |
 | INC Research Schedules Second Quarter 2017 Earnings Call for Thursday, July 27 ...
globenewswire.com - July 11 at 11:51 PM |
| INC Research Holdings, Inc. (INCR) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 10 at 10:50 PM |
| INC exec: New site collaboration 'more prudent' than acquisitions
finance.yahoo.com - July 10 at 7:50 PM |
| INC Research Schedules Second Quarter 2017 Earnings Call for Thursday, July 27, 2017
finance.yahoo.com - July 10 at 7:50 PM |
| INC Research Further Expands Catalyst Program with Launch of Psychiatry Catalyst Site Network
finance.yahoo.com - July 6 at 6:00 AM |
| INC Research Holdings, Inc. (INCR) CEO Alistair Macdonald Sells 10,555 Shares
www.americanbankingnews.com - July 5 at 10:32 AM |
| INC Research Holdings, Inc. (NASDAQ:INCR) CAO Sells $400,833.36 in Stock
www.americanbankingnews.com - July 5 at 10:32 AM |
| INC Research Holdings, Inc. to Post Q1 2018 Earnings of $0.61 Per Share, Jefferies Group Forecasts (INCR)
www.americanbankingnews.com - June 30 at 9:42 AM |
| INC Research Holdings, Inc. (INCR) Lowered to Hold at Jefferies Group LLC
www.americanbankingnews.com - June 29 at 7:36 AM |
| INC Research Grows Presence in Japan with Office Expansion and Relocation
finance.yahoo.com - June 29 at 12:29 AM |
| INC Research, inVentiv Health reveal more post-merger leadership changes
finance.yahoo.com - June 26 at 7:43 PM |
| $257.67 Million in Sales Expected for INC Research Holdings, Inc. (INCR) This Quarter
www.americanbankingnews.com - June 23 at 5:54 PM |
| Q3 2017 EPS Estimates for INC Research Holdings, Inc. (INCR) Increased by Analyst
www.americanbankingnews.com - June 22 at 8:52 AM |
| William Blair Brokers Lower Earnings Estimates for INC Research Holdings, Inc. (INCR)
www.americanbankingnews.com - June 21 at 7:58 AM |
| Zacks: Analysts Expect INC Research Holdings, Inc. (INCR) Will Post Earnings of $0.58 Per Share
www.americanbankingnews.com - June 21 at 7:34 AM |
| Head-To-Head Survey: National Research Corporation (NRCIB) & INC Research Holdings (INCR)
www.americanbankingnews.com - June 21 at 12:22 AM |
 | UPDATE: William Blair Downgrades INC Research Holdings (INCR) to Market Perform Ahead Of Merger Agreement
www.streetinsider.com - June 20 at 6:47 PM |
| Pamplona Capital Management nears deal to buy Parexel-source
finance.yahoo.com - June 20 at 6:47 PM |
| INC Research Holdings, Inc. (INCR) Rating Lowered to Market Perform at William Blair
www.americanbankingnews.com - June 20 at 10:06 AM |
| Jefferies Group LLC Reaffirms "Buy" Rating for INC Research Holdings, Inc. (INCR)
www.americanbankingnews.com - June 17 at 1:40 PM |
| Q4 2017 Earnings Estimate for INC Research Holdings, Inc. (INCR) Issued By KeyCorp
www.americanbankingnews.com - June 15 at 11:58 AM |
| INC Research to Lead the Conversation on ICH E6 R2 Preparedness at DIA 2017 Annual Meeting
finance.yahoo.com - June 14 at 7:54 PM |
| INC Research Holdings, Inc. (INCR) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 13 at 10:50 PM |
| INC Research Holdings, INC. -- Moody's assigns Ba2 to INC's new secured debt; existing ratings remain under review
finance.yahoo.com - June 13 at 5:42 PM |
| SAIC to move corporate HQ to Reston, hire COO
finance.yahoo.com - June 9 at 9:36 AM |
 | INC Research Holdings (INCR) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow
seekingalpha.com - June 7 at 5:30 PM |
| KeyCorp Research Analysts Lift Earnings Estimates for INC Research Holdings Inc (INCR)
www.americanbankingnews.com - June 7 at 8:28 AM |
| INC Research Announces 2017 “INCSights” Webinar Series to Advance Dialogue on Clinical Research
finance.yahoo.com - June 6 at 11:35 AM |
| INC Research Holdings Inc (INCR) Stock Rating Upgraded by KeyCorp
www.americanbankingnews.com - June 5 at 9:52 AM |
| Q4 2017 EPS Estimates for INC Research Holdings Inc (INCR) Lifted by SunTrust Banks
www.americanbankingnews.com - June 5 at 7:16 AM |
| Q2 2017 EPS Estimates for INC Research Holdings Inc Reduced by Analyst (INCR)
www.americanbankingnews.com - June 2 at 7:08 AM |
| SunTrust Robinson Humphrey Upgrades INC Research Holdings (INCR) to Buy
www.streetinsider.com - May 31 at 5:50 PM |
| INC Research to Present at Upcoming Jefferies Global Healthcare Conference
finance.yahoo.com - May 31 at 5:50 PM |
| INC Research Holdings Inc (INCR) Upgraded to "Buy" at SunTrust Banks, Inc.
www.americanbankingnews.com - May 31 at 7:36 AM |
| INC Research Holdings Inc (INCR) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - May 28 at 7:02 PM |
| Analysts Anticipate INC Research Holdings Inc (INCR) Will Announce Quarterly Sales of $262.02 Million
www.americanbankingnews.com - May 28 at 10:44 AM |
| $0.60 Earnings Per Share Expected for INC Research Holdings Inc (INCR) This Quarter
www.americanbankingnews.com - May 26 at 10:13 AM |
| ETFs with exposure to INC Research Holdings, Inc. : May 22, 2017
finance.yahoo.com - May 22 at 5:23 PM |
| INC Research Holdings Inc (INCR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 19 at 11:06 PM |
| INC Research Holdings, Inc. :INCR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
finance.yahoo.com - May 19 at 5:37 PM |
| INC Research, InVentiv reveal post-merger executive team
finance.yahoo.com - May 19 at 5:37 PM |
| INC Research Holdings Inc (INCR) Raised to Outperform at Robert W. Baird
www.americanbankingnews.com - May 14 at 9:12 AM |
| INC Research Holdings, Inc. – Value Analysis (NASDAQ:INCR) : May 12, 2017
finance.yahoo.com - May 12 at 6:35 PM |
| Short Interest in INC Research Holdings Inc (INCR) Expands By 4.7%
www.americanbankingnews.com - May 12 at 7:24 AM |
| INC Research (INCR) to Merge with inVentiv Health
www.streetinsider.com - May 11 at 6:31 PM |
INC Research Holdings (INCR) Chart for Wednesday, July, 26, 2017
